RedX Pharma set for IPO
This article was originally published in Scrip
Executive Summary
RedX Pharma, an expanding drug discovery company focused on the development of cancer therapeutics and anti-infectives, is aiming to raise £20m (approximately $30.2m) through an initial public offering.